Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. [electronic resource]
Producer: 20110719Description: 676-84 p. digitalISSN:- 1478-3231
- Adolescent
- Adult
- Aged
- Alanine Transaminase -- blood
- Antiviral Agents -- administration & dosage
- Biomarkers -- blood
- DNA, Viral -- blood
- Drug Administration Schedule
- Drug Resistance, Viral -- genetics
- Female
- Hepatitis B Surface Antigens -- blood
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- immunology
- Hepatitis B, Chronic -- diagnosis
- Humans
- Male
- Middle Aged
- Nucleosides -- administration & dosage
- Pyrimidinones -- administration & dosage
- Telbivudine
- Thymidine -- analogs & derivatives
- Time Factors
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.